1921
Volume 83, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Universal childhood hepatitis B vaccination was introduced in Indonesia in 1997; by 2008, coverage was estimated to be 78%. This study aimed to investigate the serologic status and virologic characteristics of hepatitis B virus (HBV) among the children in East Java. A total of 229 healthy children born during 1994–1999 were enrolled in this study. Overall, 3.1% were positive for hepatitis B surface antigen (HBsAg) and 23.6% were positive for antibody to HBsAg (anti-HBs). HBV DNA was detected in 5 of 222 HBsAg-negative carriers, which were suggested to be cases of occult HBV infection. A single amino substitution (T126I) in the S region was frequently found. HBV infection remains endemic, and the prevalence of anti-HBs remains insufficient among children in East Java, Indonesia.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2010.09-0589
2010-07-01
2017-09-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/83/1/189.html?itemId=/content/journals/10.4269/ajtmh.2010.09-0589&mimeType=html&fmt=ahah

References

  1. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS, , 2001. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135: 796800.[Crossref]
  2. Hsu HY, Chang MH, Ni YH, Chen HL, , 2004. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53: 14991503.[Crossref]
  3. Hou J, Liu Z, Gu F, , 2005. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2: 5057.[Crossref]
  4. Lee WM, , 1997. Hepatitis B virus infection. N Engl J Med 337: 17331745.[Crossref]
  5. Creati M, Saleh A, Ruff TA, Stewart T, Otto B, Sutanto A, Clements CJ, , 2007. Implementing the birth dose of hepatitis B vaccine in rural Indonesia. Vaccine 25: 59855993.[Crossref]
  6. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R, , 1995. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345: 14061407.[Crossref]
  7. Lee PI, Chang LY, Lee CY, Huang LM, Chang MH, , 1997. Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 176: 427430.[Crossref]
  8. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ, , 2001. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 19: 39193926.[Crossref]
  9. Howard CR, , 1995. The structure of hepatitis B envelope and molecular variants of hepatitis B virus. J Viral Hepat 2: 165170.[Crossref]
  10. Allain JP, , 2004. Occult hepatitis B virus infection. Transfus Clin Biol 11: 1825.[Crossref]
  11. Mu SC, Lin YM, Jow GM, Chen BF, , 2009. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 50: 264272.[Crossref]
  12. Kao JH, Chen PJ, Lai MY, Chen DS, , 2002. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection. J Med Virol 68: 216220.[Crossref]
  13. Pinarbasi B, Onel D, Cosan F, Akyuz F, Dirlik N, Cakaloglu Y, Badur S, Besisik F, Demir K, Okten A, Kaymakoglu S, , 2009. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey. Liver Int 29: 227230.[Crossref]
  14. World Health Organization, 2009. Review of National Immunization Coverage 1980–2008. Available at: http://www.who.int/immunization_monitoring/data/idn.pdf. Accessed August 6, 2009.
  15. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Suzuki S, Kimura Y, Ueda R, Butterworth LA, Cooksley WGE, , 2001. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol 82: 883892.[Crossref]
  16. Yamamura T, Tanaka E, Matsumoto A, Rokuhara A, Orii K, Yoshizawa K, Miyakawa Y, Kiyosawa K, , 2003. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter. J Med Virol 70: 545552.[Crossref]
  17. Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, Kawaguchi R, Tanaka S, Yoshiba M, Kohara M, , 1999. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 37: 28992903.
  18. Tamura K, Dudley J, Nei M, Kumar S, , 2007. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24: 15961599.[Crossref]
  19. Huang ML, Liao WL, Ho MS, , 2007. HBV serological markers of vaccinated children in remote areas of Taiwan: emphasis on factors contributing to vaccine failure. Vaccine 25: 63266333.[Crossref]
  20. Young MD, Schneider DL, Zuckerman AJ, Du W, Dickson B, Maddrey WC, US Hepacare Study Group, 2001. Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine. Hepatology 34: 372376.[Crossref]
  21. Zuckerman JN, Zuckerman AJ, Symington I, Du W, Williams A, Dickson B, Young MD, ; UK Hepacare Study Group, 2001. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines. Hepatology 34: 798802.[Crossref]
  22. He C, Nomura F, Itoga S, Isobe K, Nakai T, , 2001. Prevalence of vaccine-induced escape mutants of hepatitis B virus in the adult population in China: a prospective study in 176 restaurant employees. J Gastroenterol Hepatol 16: 13731377.[Crossref]
  23. World Health Organization, 2001. Introduction of Hepatitis B Vaccine into Childhood Immunization Services. Available at: http://www.who.int/vaccines-documents/DocsPDF01/ Accessed August 6, 2009.
  24. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, Paupunwatana S, Chaiear K, Khwanjaipanich S, Poovorawan Y, , 2006. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 11: 14961502.[Crossref]
  25. Mu SC, Lin YM, Jow GM, Chen BF, , 2009. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 50: 264272.[Crossref]
  26. Kao JT, Wang JH, Hung CH, Yen YH, Hung SF, Hu TH, Lee CM, Lu SN, , 2009. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan. Vaccine 27: 18581862.[Crossref]
  27. Chemin I, Trépo C, , 2005. Clinical impact of occult HBV infections. J Clin Virol 34: S15S21.[Crossref]
  28. Thammanichanond D, Kunakorn M, Settaudom C, Khupulsup K, , 2002. Reversed passive hemagglutination test fails to detect HBsAg in a number of HBeAg positive sera. Asian Pac J Allergy Immunol 20: 135137.
  29. Lau DT, Ma H, Lemon SM, Doo E, Ghany MG, Miskovsky E, Woods GL, Park Y, Hoofnagle JH, , 2003. A rapid immunochromatographic assay for hepatitis B virus screening. J Viral Hepat 10: 331334.[Crossref]
  30. Sato K, Ichiyama S, Iinuma Y, Nada T, Shimokata K, Nakashima N, , 1996. Evaluation of immunochromatographic assay systems for rapid detection of hepatitis B surface antigen and antibody, Dainascreen HBsAg and Dainascreen Ausab. J Clin Microbiol 34: 14201422.
  31. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M, , 1994. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 68: 26712676.
  32. Lee KM, Kim YS, Ko YY, Yoo BM, Lee KJ, Kim JH, Hahm KB, Cho SW, , 2001. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 16: 359362.[Crossref]
  33. Ren F, Tsubota A, Hirokawa T, Kumada H, Yang Z, Tanaka H, , 2006. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change. Gene 383: 4351.[Crossref]
  34. Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A, , 2009. Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol 81: 815825.[Crossref]
  35. Ruiz-Tachiquín ME, Valdez-Salazar HA, Juárez-Barreto V, Dehesa-Violante M, Torres J, Muñoz-Hernández O, Alvarez-Muñoz MT, , 2007. Molecular analysis of hepatitis B virus “a” determinant in asymptomatic and symptomatic Mexican carriers. Virol J 4: 6.[Crossref]
  36. Lusida MI, Nugrahaputra VE, Soetjipto Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, Hotta H, , 2008. Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 46: 21602166.[Crossref]
  37. Utsumi T, Lusida MI, Yano Y, Nugrahaputra VE, Amin M, Juniastuti Soetjipto, Hayashi Y, Hotta H, , 2009. Complete genome sequence and phylogenetic relatedness of hepatitis B virus isolates in Papua, Indonesia. J Clin Microbiol 47: 18421847.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.09-0589
Loading
/content/journals/10.4269/ajtmh.2010.09-0589
Loading

Data & Media loading...

  • Received : 30 Sep 2009
  • Accepted : 24 Mar 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error